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CLINICAL INVESTIGATIONS 
H 
The interplay between endogenous 
catechoiamines and induced ventricular 
tachycardia during electrophysiologic testing 
Plasma spinephrine end norepinephrine concentrations were measured before, during, and 
shortly after induced ventricular tachycardia (VT) in 22 selected patients. Sustained, unimorphic 
VT was induced by programmed ventricular stimulation and terminated after 45 to 364 seconds 
by overdrive pacing in ail patients. in no patient did VT result in loss of consciousness. The 
baseline plasma catechoiamine concentrations did not correlate with the baseline right 
ventricular effective refractory period, the cycle length of induced VT, or the number of 
extrastimuli required to induce VT. induced VT was not associated with a significant increase in 
the mean plasma epinephrine concentration. in contrast, the plasma norepinephrlne 
concentration increased from a mean baseline level of 317 + 136 pg/mi (mean it standard 
deviation) to 416 j, 220 pg/mi during VT @ < 0.01) and increased further to 569 + 367 pg/mi 
shortly after VT (p < 0.01). The plasma noreplnephrine concentration shortly after VT correiated 
with the rate and duration of VT and with the magnitude of decrease in mean blood pressure 
during VT (p < 0.0s for each). in eight patients the same configuration of VT was induced on two 
sequential attempts; in five patients the same number of extrastimuli were required for the 
second Induction of VT as for the first, whereas in three patients fewer extrastimuli were 
required. Plasma catehoiamine concentrations were not higher in patients requiring fewer 
extrastimuli to induce the second episode of VT, either shortly after the flrst episode of VT or 
shortly after the second episode of VT. in conclusion, plasma catechoiamines do not influence 
baseline ventricular refractoriness, the cycle length of induced VT, or the VT induction technique. 
Induced VT, which does not require termination by direct-current countershock, Is genera& 
associated with little or no increase in plasma epinephrine and a variable increase In plasma 
norepinephrine concentration, depending on the severity and duration of hypotension during VT. 
The plasma catechoiamine response to VT does not affect a second Induction of VT. Therefore, 
endogenous catechoiamines exert little influence on the results of eiectrophysloiogk testing in 
patients with sustained VT which does not require termination by direct-current countershock. 
(AM HEART J 1967;113:227.) 
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Isoproterenol administered during programmed 
ventricular stimulation shortens the ventricular 
effective refractory period and may facilitate the 
induction of ventricular tachycardia (VT).ls2 This 
suggests the possibility that release of endogenous 
catecholamines may influence the ventricular effec- 
tive refractory period and the technique necessary 
to induce VT during an electrophysiologic study. 
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However, no data are available ( n the relationshiIi 
between endogenous catecholam ne levels and the 
ventricular effective refractory pe iod or the number 
of extrastimuli required to induc ! VT. 
A prior study demonstrated tin t when VT requir- 
ing direct-current countershock is induced during 
programmed ventricular stimulat .on, there is a sev 
eral-fold increase in the plasmtil epinephrine and 
norepinephrine concentrations, ir association with 8. 
10 to 40 msec decrease in the ventricular effective’ 
refractory period for up to 10 lninutes after thr, 
countershock. However, no stucllies to date, have 
quantitated the plasma catecholtmine response to 
VT which does not require direct-current counter- 
shock. It is, therefore, unknown whether the cate- 
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Table 1. Characteristics of VT induced in 22 patients 
Characteristics Mean k SD Range 
Bundle branch block configuration 
Right bundle branch block 
Left bundle branch block 
Cycle length (msec) 
Number of extrastimuli required 




Duration of VT (set) 
12 - 
10 - 
328 + 62 240-410 
2 + 0.6 l-3 
4 - 
14 - 
4 - 135 + 92 45 384 
Mean arterial pressure (mm Hg) 
Baseline 
At 30-45 seconds after onset 
of VT 
95 z!z 12 73-120 
76 ZIZ 17 50-117 
Abbreviations: SD = standard deviation; VT = ventricular tachycardia. 
cholamine response to the frrst induction of VT may 
affect a second induction of VT. 
This prospective study was designed to assess the 
interplay between endogenous catecholamines and 
VT induced during an electrophysiologic study. An 
attempt was made to answer the following ques- 
tions: (1) Is there a relationship between the base- 
line plasma epinephrine or norepinephrine concen- 
tration and the baseline ventricular effective refrac- 
tory period, the cycle length of induced VT, or the 
number of extrastimuli required to induce VT? (2) 
What determines the magnitude of rise in plasma 
catecholamines during VT not requiring counter- 
shock? (3) Does the plasma catecholamine response 
to the first induction of VT influence the next 
induction of VT? 
METHODS 
The subjects of this study were 22 patients who under- 
went an electrophysiologic study because of a history of 
sustained, unimorphic VT. Sustained, unimorphic VT was 
inducible by programmed ventricular stimulation in each 
patient, and none of the patients required direct-current 
countershock to terminate the VT. In each patient, the 
VT persisted until it was terminated by overdrive pacing. 
All 22 patients were men, and their mean age was 60 +- 10 
years (mean + one standard deviation). All patients had 
undergone right and left heart catheterization and coro- 
nary angiography. Eighteen patients had coronary artery 
disease (with a history of myocardial infarction in 16), one 
patient had dilated cardiomyopathy, one patient had 
arrhythmogenic right ventricular dysplasia, and two 
patients had no evidence of structural heart d&ease. Eight 
patients had congestive heart failure, with a mean left 
ventricular ejection fraction, by contrast or radionuclide 
ventriculography, of 0.26 + 0.03. The mean left ventricu- 
lar ejection fraction in the 14 patients without congestive 
heart failure was 0.48 f 0.10. 
ElectrophysialQgic study protocol. Electrophysiologlc 
studies were performed in the fasting, unsedated state 
after informed consent had been obtained. All antiar- 
rhythmic drugs were discontinued at least five half-lives 
before the study. Electrode catheters were inserted percu- 
taneously in a femoral vein and positioned against the 
right ventricular apex and either the right ventricular 
septum or outflow tract. A short 5 French cannula was 
inserted into a femoral artery for continuous monitoring 
of the arterial pressure. Leads V1, I, and III, the intracar- 
diac electrograms, and the arterial pressure were dis- 
played on an oscilloscope and recorded on an Electronics 
for Medicine VR-16 or Siemens-Elema Mingograf 7 
recorder. Programmed ventricular stimulation was per- 
formed with a programmable stimulator (Bloom Asso- 
ciates, Ltd., Narbeth, Pa.). The pacing stimuli were 2 msec 
in duration and twice the diastolic threshold. 
Programmed ventricular stimulation was performed 
with the use of basic drive trains of eight stimuli at cycle 
lengths of 600, 500, and 400 msec. Single and double 
extrastimuli were introduced at the right ventricular apex, 
then at the second right ventricular site, followed by triple 
extrastimuli at the same two sites. In each patient, 
sustained VT was terminated by right ventricular over- 
drive pacing at cycle lengths 20 to 50 msec shorter than 
the VT cycle length. If direct-current countershock was 
required to terminate VT, the patient was not included in 
this study. 
Catecholamine determinations. Two baseline samples 
of blood were obtained 5 minutes apart from the femoral 
artery, 15 minutes after placement of the electrode cathe- 
ters in the right ventricle. A blood sample was obtained 
between 30 and 45 seconds after the onset of VT, before 
any attempts to terminate the VT by pacing. After the 
sample was drawn, right ventricular overdrive pacing was 
initiated to terminate the VT. Another blood sample was 
drawn between 15 and 30 seconds after the termination of 
VT. 
The relationship between plasma catecholamines and 
the reproducibility of the technique used to induce VT 
was assessed in eight patients in whom the same configu- 
ration of VT was induced on successive attempts. Imme- 
diately after the post-VT blood sample was drawn, pro- 
grammed ventricular stimulation was repeated at the 
same right ventricular site and basic drive cycle length 
used to induce the first episode of VT. A blood sample was 
drawn approximately every minute until VT was rein- 
duced. Plasma epinephrine and norepinephrine concen- 
trations were measured by means of a single isotope 
enzymatic assaye4 All samples from a given patient were 
analyzed in the same assay. 
Data analysis. A paired t test demonstrated no signifi- 
cant difference between the two baseline epinephrine and 
norepinephrine concentrations, and therefore the average 
of the two baseline values was used in the statistical 
analyses. The plasma catecholamine concentrations 
before, during, and after VT were compared by analysis of 
variance with repeated measures. Correlation coefficients 
were determined by linear regression analysis. Student’s t 
test was used to compare plasma catecholamine concen- 
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Fig. 1. Plasma epinephrine (Epi) concentrations before, during (30 to 46 seconds after onset), and 
shortly after an episode of induced VT. Individual data from-22 patients are shown, as well as mean 2 1 
SD. - 
trations in patients who required the same vs fewer 
extrastimuli to induce VT on a second occasion. 
RESULTS 
Relationship between baseline plasma catecholam- 
ines and refractoriness. The mean right ventricular 
effective refractory period determined at a basic 
drive cycle length of 500 msec was ‘239 + 16 msec. 
There was not a significant correlation between 
either the baseline epinephrine or norepinephrine 
concentration and the right ventricular effective 
refractory period (r = 0.1 and 0.2, respectively; 
p > 0.3 for both). 
Characteristics of induced VT. Unimorphic VT was 
induced in each of the 22 patients. The characteris- 
tics of the induced VT are described in Table I. 
Effect of VT on plasma catecholamine concentra- 
tions. There were no significant differences between 
mean plasma epinephrine concentrations in the 
baseline state, 164 k 58 pg/ml; during VT, 180 + 91 
pgfml; and shortly after termination of the VT, 
219 + 180 pg/ml (p > 0.05; Fig. 1). However, in 4 of 
the 22 patients the plasma epinephrine concentra- 
tion shortly after termination of VT exceeded the 
baseline concentration by more than 100 pg/ml. 
The mean plasma norepinephrine concentration 
in the baseline state was 317 + 136 pg/ml. There 
was a significant increase in the mean plasma nor- 
epinephrine concentration to 418 f 220 pg/ml dur- 
ing VT @ < 0.01) and a further significant increase 
to 569 + 387 pg/ml shortly after termination of the 
VT 0, < 0.01; Fig. 2). A progressive increase in the 
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Fig.’ 2. Plasma norepinephrine (NE) concentrations 
before, during (30 to 45 seconds after onset), and shortly 
after an episode of induced VT. Format as in Fig. 1. 
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Fig. 3. Correlation between duration of induced VT and plasma norepinephrine concentration shortly 
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Fig. 4. Correlation between cycle length of induced VT and plasma norepinephrine concentration shortly 
after termination of VT. 
baseline state to during VT to shortly after VT was 
obwrved in 15 of 22 patients. 
Rdatbnship between baseMe pleama- cetecholam- 
ines and induced VT. Thepe was not a s&&cant 
correlation between either the 
or norepinephrine concentr 
length of induced VT (r = 0.06 and 0.01, reqmctive- 
ly; p > 0.8 for both). Comparing tk-f<wr p&e&a in 
whom VT was induced by a single e&a&k&s, the 
14 in whom it was induced by twosfb’gatimuli, and 
the four in whom it was induced 
muli, there were no si&&xmt 
baseline epinephrine or norep~e concentra- 
tions between the three groups of patients 
0, > 0.05). 
Pk8Sm catecho4aminea ohoiuy after termination of 
VT. The werage duration of VT was 135 -F 92 
seconds, w&h a range of 45 to 384 seconds. There 
correlation between the dura- 
plasma epinephrine concentra- 
termination of VT (r = 0.3; 
r, there was a sign&ant correla- 
of VT and the plasma 
n shortly *r termina- 
tion of VT (r - 0.5, p < 0.06; Fig. 3). 
There was not a sign&ant corre&ion between 
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Fig. 5. Correlation between decrease in mean arterial blood pressure (BP) during VT and plasma 
epinephrine and norepinephrine concentrations shortly after termination of VT. 
the VT cycle length and the plasma epinephrine 
concentration shortly after termination of VT 
(r = -0.4; p > 0.05). However, there was a signifi- 
cant negative correlation between the cycle length of 
VT and the plasma norepinephrine concentration 
shortly after termination of VT (r = -0.5, p < 0.05; 
Fig. 4). 
There was a significant correlation between the 
change in mean blood pressure during VT and the 
plasma epinephrine and norepinepbrine concentra- 
tions shortly after termination of VT (r = 0.49 and 
0.47, respectively; p < 0.05 for both; Fig. 5). There 
was also a significant correlation between the change 
in mean blood pressure during VT and the change 
from baseline in the plasma epinephrine and norepi- 
nephrine concentration shortly after termination of 
VT (r = 0.51; p < < 0.05, and r = 0.59; p < 0.01, 
respectively). 
Plasma catecholamlnes in patients undergoing two 
inductions of VT. Plasma catecholamine concentra- 
tions were measured in serial fashion approximately 
every minute during programmed ventricular stimu- 
lation in eight patients in whom the same configura- 
tion of VT was induced on two occasions. In five 
patients the same number of extrastimuli was 
required for the first and second induction of VT, 
whereas in three patients a smaller number of 
extrastimuli was required for the second induction 
of VT as compared to the first induction. 
The plasma epinephrine and norepinephrine con- 
centrations in the baseline state, shortly after the 
first episode of VT, and shortly after the second 
induction of VT are listed in Table II. Of note is that 
there were no sign&ant differences between the 
plasma epinephrine concentrations in patients who 
required either the same or fewer extrastimuli for 
the two inductions of VT. The plasma norepineph- 
rine concentration shortly after the first episode of 
Table II. Plasma catecholamines in patients undergoing 
two inductions of VT 
No. of extrastimuli* 
Same Fewer 
(n = 5) (n = 3) P 
Plasma concentrations (pg/ml) 
Baseline 
Epinephrine 165 k 15t 137 f 25 NS 
Norepinephriie 324 k 143 208 f 46 NS 
Shortly after first VT 
Epinephrine 170 f 92 157 f 59 NS 
Norepinephrine 443 + 152 233 -t 51 -Co.05 
Shortly before second VT 
Epinephrine 154 rt 90 142 + 43 NS 
Norepinephrine 362 f 150 221 + 40 NS 
Elapsed time between 163 f 62 58 +- 19 <0.05 
first and second VT 
(aed 
Abbreviations: NS = not significant; VT = ventricular tachycardia. 
*Number of extrastimuli required for second induction of VT compared to 
first induction. 
tMean + standard deviation. 
VT was higher in patients who required the same 
number of extrastimuli for the two VT inductions 
than in patients who required fewer extrastimuli for 
the second VT induction (p < 0.05). However, there 
was not a signifkant difference in the plasma nor- 
epinephrine concentration between the two groups 
of patients shortly after the second episode of VT 
was induced. 
The elapsed time between the end of the first 
episode of VT and the onset of the second VT was 
significantly shorter in patients who required fewer 
extrastimuli for the second VT induction than in 
patients who required the same number of extrasti- 
muli for the two VT inductions (56 +- 19 seconds vs 
163 + 62 seconds, p < 0.05; Table II). 
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In two patients, the cycle length of the second 
induced VT was 20 to 30 msec shorter than the cycle 
length of the first induced VT, whereas in six 
patients the two episodes of VT had the same cycle 
length. Comparing these two subgroups there were 
no differences in the plasma epinephrine or norepi- 
nepbrine concentration either shortly after the first 
episode of VT was terminated or shortly after the 
second episode of VT was induced. 
DISCUSSION 
The results of this study suggest that endogenous 
catecholamines exert little influence on the results 
of electrophysiologic testing in patients who have 
inducible unimorphic VT which does not require 
direct-current countershock to terminate. Whereas 
rapid VT that results in loss of consciousness and 
that is terminated by direct-current countershock is 
associated with a mean increase of fivefold in the 
plasma epinephrine concentration,3 sustained VT 
that is not associated with loss of consciousness and 
that can be terminated by right ventricular over- 
drive pacing is generally associated with little or no 
rise in the plasma epinephrine concentration, indi- 
cating little or no adrenal medullary response. 
Although the plasma norephinephrine concentra- 
tion increased significantly in association with VT in 
the present study, the magnitude of the rise was, on 
the average, less than twofold. In patients in whom 
the same configuration of VT was induced on two 
occasions, a decrease in the number of extrastimuli 
required to induce VT was not related to an increase 
in the plasma catecholamine concentrations. There- 
fore, there appears to be little interplay between 
endogenous catechlamines and induced VT when 
direct-current countershock is not employed during 
an electrophysiology study. 
In the present study, no correlation was demon- 
strated between the baseline right ventricular 
effective refractory period and the baseline plasma 
epinephrine or norepinephrine concentration. 
Therefore, it appears that the ventricular effective 
refractory period in the baseline state is not influ- 
enced by plasma catecholamine concentrations and 
that inter-patient variation in ventricular refractori- 
ness is not related to differences in the baseline 
degree of adrenergic activation. 
The factors that determine the number of extra- 
stimuli required to induce VT are unclear. Because 
isoproterenol has been demonstrated to facihtate 
the induction of VT by programmed ventricular 
stimulation, we considered the possibility that the 
number of extrastimuli required to induce VT may 
be related to the plasma epinephrine or norepineph- 
rine concentration at the time of programmed stim- 
ulation. No difference was found in the mean plasma 
epinephrine or norepinephrine concentration be- 
tween patients in whom VT was induced by single, 
double, or triple extrastimuli. Although the cate- 
cholamine concentrations were measured before 
instead of during programmed stimulation, a prior 
study demonstrated that programmed stimulation 
with a protocol identical to the one used in the 
present study does not affect plasma catecholamine 
concentrations3 Therefore, baseline plasma cate- 
cholamine levels do not appear to be a determinant 
of the number of extrastimuli required to induce 
VT. 
Although there was not a significant increase in 
the mean epinephrine concentration in response to 
induced VT, the plasma epinephrine concentration 
increased to a level of greater than 550 pg/ml in 3 of 
22 patients. There was aIs0 a heterogeneous 
response of the plasma norepinephrine concentra- 
tion to induced VT. Whereas the mean plasma 
norepinephrine concentration increased by less than 
twofold, there was a twofold or greater increase in 
the plasma norepinephrine concentration in 6 of 22 
patients. The plasma epinephrine concentration 
either during or shortly after VT did not correlate 
with the VT cycle length or duration, or with the 
blood pressure during the VT. However, there was a 
positive correlation between the norepinephrine 
concentration shortly after VT and both the dura- 
tion of VT and the magnitude of the decrease in 
blood pressure during VT, and a negative correla- 
tion between the plasma norepinephrine concentra- 
tion and the VT cycle length. These data suggest 
that the magnitude of increase in the plasma norepi- 
nephrine concentration in response to VT is deter- 
mined, at least in part, by the severity and duration 
of hypotension during VT. It appears that the 
change in blood pressure may be more important 
than the absolute blood pressure in provoking a 
catecholamine response during VT. 
In a prior study it was demonstrated that 
although unimorphic VT is usually reproducibly 
inducible, the number of extrastimuli required to 
induce the VT may vary in sequential induction 
attempts5 A goal of this study was to determine 
whether changes in the number of extrastimuli 
required to induce VT may be related to increases in 
the plasma catecholamine concentrations that occur 
during the first episode of VT. In the eight patients 
in whom this was assessed, a decrease in the number 
of extrastimuli required to induce the second epi- 
sode of VT could not be attributed to changes in the 
plasma catechohtmine concentrations, since there 
was not a significant difference in the plasma epi- 
nephrine or norepinephrine concentrations before 
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the induction of the first and second episodes of VT. demonstrated in this study, interplay between local 
Furthermore, the plasma norepinephrine doncentra- myocardial norepinephrine and induced VT cannot 
tion shortly after the first induction of VT was be ruled out. A second limitation is that changes in 
significantly higher among the five patients who the number of extrastimuli needed to induce VT 
required the same number of extrastimuli for the could be assessed in only eight patients. This was 
two inductions of VT than among the three patients because in many patients a different configuration 
in whom the second induction of VT required fewer of VT was induced on a second attempt. A third 
extrastimuli than the first. These observations sug- limitation is that data on mean blood pressures 
gest that a change in the number of extrastimuli during VT are only estimates. Precise measurement 
needed to induce VT cannot be attributed to adren- of the mean blood pressure during VT was not 
ergic activation resulting from the first episode of possible because of fluctuations over time and dur- 
VT. ing periods of overdrive pacing. 
In a prior study of the catecholamine response to 
VT associated with loss of consciousness and termi- 
nated by direct-current countershock, increases of 
several-fold in the plasma epinephrine and norepi- 
nephrine concentrations were observed at 1 minute 
after the countershock, but by 3 minutes after the 
countershock the plasma catecholamine concentra- 
tions were no longer significantly greater than base- 
line.3 Associated changes in ventricular refractori- 
ness were greatest at 1 and 3 minutes after the 
countershock and did not persist for more than 10 
minutes. These data indicate that even when eleva- 
tions in plasma catecholamine concentrations are of 
large magnitude, the duration of the rise and associ- 
ated electrophysiologic effects are shortlived. It may 
be possible that an episode of induced VT that is 
accompanied by marked and prolonged hypotension 
and that results in a several-fold increase in plasma 
catecholamines, could influence a second episode of 
VT induced within 1 to 3 minutes after termination 
of the first episode. However, in practice, there is 
usually a rest period of several minutes between 
episodes of induced VT. The relatively minor 
increase in plasma norepinephrine concentration 
that generally occurs in response to VT that is 
hemodynamically stable and that does not necessi- 
tate direct-current countershock is therefore highly 
unlikely to be of clinical importance. 
In summary, the baseline state of adrenergic 
activity does not appear to be an important determi- 
nant of ventricular refractoriness, the number of 
extrastimuli required to induce VT, or the cycle 
length of induced VT. When sustained VT that is 
not accompanied by loss of consciousness and that 
does not require direct-current countershock is 
induced by programmed ventricular stimulation, 
there is generally little or no increase in the plasma 
epinephrine concentration and only a modest 
increase in the plasma norepinephrine concentra- 
tion. The plasma catecholamine response is likely to 
be related to the magnitude and duration of the 
decrease in blood pressure that accompanies the VT. 
Adrenergic activation during induced VT does not 
appear to account for changes that may occur in the 
number of extrastimuli required to induce a subse- 
quent episode of the same configuration of VT. The 
increases in plasma catecholamine concentration 
that may accompany an episode of induced VT not 
requiring countershock appear to be of litle or no 
physiologic consequence. 
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barth. 
Adrenergic activation would be expected to accel- 
erate the rate of VT. Among the eight patients in 
whom the same configuration of VT was induced on 
two occasions in rapid succession, the cycle length of 
the second episode of VT was shorter than the cycle 
length of the first episode in only two patients. This 
provides additional evidence that the catecolamine 
response to hemodynamically significant VT is usu- 
ally of little or no physiologic consequence. 
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